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IInfertility centres are increasingly dealing withcouples with HIV who strongly want to beparents.1 Preconceptional counselling and re-
productive assistance for such couples have
significant ethical and practical implications for
the couple and the carers. This article addresses
the ethical and practical issues concerned in
assisting them to limit negative consequences,
both for the couples and the future child.
In general, there are four underlying principles
that constitute the framework of medical ethics:
(I) Primum non nocere: first of all, do no harm
(ii) Beneficence: do good
(iii) Autonomy: respect the individual
(iv) Justice: honest and fair care.
Thus, these principles of medical ethics stress
the need to do as much good as possible while
keeping the harm/risks of any intervention to the
minimum. To respect the patient’s autonomy, they
need to be informed of the diagnosis and
management options (pros and cons) in terms
they understand and be allowed to make choices
for their care without undue pressures from
carers. Finally, the treatment must be adminis-
tered in a just and fair manner.2
We present three clinical scenarios of couples
demonstrating the dilemmas faced in the man-
agement of these situations.
(1) The man is infected with HIV and the woman
is not
(2) The woman is infected with HIV and the man
is not
(3) Both the man and the woman are infected.
When these couples are fertile (for example,
they have conceived spontaneously in the past)
medical intervention aims at reducing the risk of
viral transfer to the uninfected partner and the
future child. This does not pose a substantial
ethical problem, although those against these
couples conceiving can argue that providing
preconception counselling may encourage them
to conceive, thus posing a risk for the uninfected
partner and/or the child and that this risk would
not be present otherwise.
In couples who have already tried to conceive
unsuccessfully, medical intervention permits the
conception of a child who is at risk of acquiring
HIV, even with optimal reproductive care. It can
be debated whether the couple’s desire to have a
child justifies medical intervention that involves
the potential risk of infection for the healthy
partner and/or the child.
When only theman is infected with HIV, semen
washing and reproductive technology can reduce
and possibly eliminate the risk of infection for
both the woman and the conceptus. When only
the woman is infected, insemination with the
partner’s semen eliminates the risk of infection
for the man, but the infant will be exposed to the
risk of vertical acquisition of HIV from the
infected mother. When both partners are in-
fected, one partner having infected the other and
both are antiretroviral treatment naive, they may
conceive on their own, as there is no reproductive
technology that may reduce the risk of infection
for the child.When the man and the woman were
infected at different times or from different
sources, the viral mutations may vary according
to the length of exposure to specific antiretroviral
drugs. In this situation, semen washing reduces
the possibility of transmission of mutated virus
through unprotected penetrative intercourse,
which may create a double infection in the
partners.3
Preconception counselling should help the
woman to modify or initiate antiretroviral treat-
ment to reduce both embryo-fetal toxicity and
risk of vertical transmission.4
To illustrate these scenarios, we present each as
a case history.
SCENARIO 1
In a couple where the man is infected with HIV
and the woman is not, she is at risk of contracting
the infection if she tries to achieve fertilisation
through unprotected intercourse.
Case history
A 37 years old man living in a rehabilitation com-
munity for 7 years asked for reproductive
assistance to have a child. He had acquired HIV
infection through drug use but his wife was
uninfected and healthy. They had been married
for 5 years and, apart from a brief period at the
start of their relationship, they had regularly used
condoms to reduce the risk of sexual transmis-
sion of HIV. With his current antiretroviral
regimen, he had undetectable viraemia and was
very tempted to try for a pregnancy by empirically
timed unprotected intercourse. The genitourinary
medicine specialist had discouraged him from
spontaneous attempts at conception and referred
him to us for counselling. During the first
meeting the couple were informed that 10% of
males with undetectable viral load in blood
plasma, have detectable cell associated and cell
free virus in their semen and that the chances of
pregnancy per episode of unprotected penetrative
sex is approximately 15%, when no infertility fac-
tors are present. They were told that there are no
data on the transmission risk in this setting and
that usually a number of attempts are required to
achieve fertilisation and therefore the cumulative
risk of infection can be significant. They were
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advised to undergo tests to ascertain a normal
fertility potential and offered reproductive assist-
ance through semen washing, coupled with
intrauterine insemination or extracorporeal ferti-
lisation. The couple had to be treated for chlamy-
dial infection and the man required prolonged
antibacterial treatment for prostatitis, which was
responsible for reduced semen motility. The
woman conceived on the third cycle of insemina-
tion with washed semen and no fertility drugs
were required as her hormonal profile was
optimal. She was seronegative during her 3
monthly serological screening until delivery and
the child was born uninfected and healthy.
Discussion
Transmission of HIV may follow a single penetra-
tive intercourse, the risk being approximately
1:500–1:1000 per sexual encounter.5 6 Thus, the
advice to try spontaneously during the fertile
period for a pregnancy in these HIV discordant
couples carries a risk, which is proportional to the
number of attempts, although the pattern of
transmission is not linear. The total risk of infec-
tion may be increased further by the additional
unprotected acts of recreational sex, as the couple
may perceive that they are at low risk of sexual
transmission.
In 1997, Mandelbrot et al reported the outcome
of 104 consecutive pregnancies in 92 HIV negative
women with HIV positive partners. All pregnan-
cies were natural conceptions, occurring after
basic infertility screening was carried out. The
couples were taught to identify signs of ovulation
to minimise chances of viral transmission. There
were 92 pregnancies, four abortions, six miscar-
riages, and two were lost to follow up in the sec-
ond trimester. In this group, there were two sero-
conversions at 7 months of pregnancy and two
postpartum—that is, the risk of seroconversion
was 4/92 (4.3%).7 This study predates the use of
triple antiretroviral therapy and thus the infected
males included were unlikely to have had
undetectable viral load in their plasma and
semen.
In contrast, Semprini et al in Milan have been
providing assisted conception to serodiscordant
couples through timed insemination attempts
after seminal processing to free spermatozoa from
HIV containing seminal plasma and seminal
leucocytes.8 9 To date, nearly 3000 cycles of intra-
uterine insemination (IUI) or extracorporeal fer-
tilisation have been completed without any case
of HIV infection to the woman or to the children
born through this method.
Seminal processing of ejaculates from HIV
positive males is carried out through a three step
method. The gradient centrifugation step, which
traps the seminal leucocytes, is followed by wash-
ing of the recovered spermatozoa to eliminate
traces of HIV rich seminal plasma and the
spontaneous migration step which separates
motile sperms from immobile seminal leucocytes
that may have filtered through the first two
processing steps. The success of this method has
been supported by flow cytometric analysis,
which has shown that HIV receptors (CD4, CCR5,
and CXCR4) are absent on the sperm surface.10
In addition to Semprini’s centre in Milan, there
are other European collaborating centres in
Barcelona, Spain; Chelsea and Westminster Hos-
pital, London and in Birmingham, United King-
dom; St Gallen, Switzerland; Mannheim, Ger-
many, and Toulouse, France, which are providing
reproductive assistance to HIV discordant cou-
ples. Intrauterine transfer of washed semen is not
indicated in HIV discordant couples with untreat-
able infertility problems impeding in vivo concep-
tion. These couples should be helped with
extracorporeal fertilisation techniques similar to
those who fail to conceive after repeated IUI
attempts. In some instances poor seminal quality
requires direct gamete manipulation with injec-
tion of the washed spermatozoa directly into the
egg (ICSI, intracytoplasmic sperm injection) to
achieve fertilisation.11 12 A small number of ICSI
attempts have been reported in HIV discordant
couples, when compared to the number of IUI
and standard in vitro fertilisation (IVF) trials.13 14
No case of female or infant infection has been
reported after ICSI, but couples undertaking ICSI
should be informed that safety is based on a lim-
ited number of trials. The possibility that free
virus can be attached to the external acrosomal
membrane, which is eliminated during spontane-
ous egg penetration but not with ICSI, might
potentially render this method riskier than IUI or
IVF. Based on this consideration, IUI and IVF
should be the first option of reproductive technol-
ogy in HIV discordant couples who do not have a
clinical indication for ICSI.
SCENARIO 2
In the second scenario, a 26 year old HIV positive
woman presented to the assisted conception unit
with her HIV negative husband to discuss the
implications of pregnancy. Her CD4 count was
0.72 × 109/l and her HIV RNA plasma load was
below 50 copies/ml. She had been using condoms
regularly to avoid conception and protect her
partner from sexual transmission. Following
extensive counselling spread over weeks, the cou-
ple decided to go ahead with a pregnancy. The
woman was helped to make a decision on
whether to stop medication during the first
trimester, advised on the benefit of pharmacologi-
cal prophylaxis of vertical transmission coupled
with elective abdominal birth and avoidance of
breast feeding. They were taught how to perform
artificial insemination by the husband’s sperm.
The husband produced a semen sample into a pot
and then, using a 5 ml syringe and a quill,
aspirated the seminal fluid. He then injected the
semen high into the vagina. They were advised to
keep a temperature chart or to buy an ovulation
kit to determine when ovulation was occurring.
They were advised to repeat this procedure over
six cycles with pregnancy being obtained in three.
At other times they were recommended to engage
only in condom protected penetrative sex.
Discussion
This scheme of reproductive counselling and
at-home reproductive assistance eliminates the
risk of infection for the man. Potentially, also the
conception delay may be shortened as insemina-
tion attempts are timed to ovulation. Genital
infections should be excluded in the man as they
can be transmitted with the insemination at-
tempts, while assessment of tubal patency may be
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unnecessary if conception occurs within 6
months, as the procedure carries no risk of infec-
tion for the uninfected partner.
The woman on antiretroviral treatment should
receive information on the effect of discontinuing
therapy in the first trimester to avoid potential
teratogenesis. At present there are no data to sup-
port or refute this. Her immunological and
virological situation should be compatible with
such a break in treatment and she must be
informed that its effect on viral resistance is
unclear at present. Asymptomatic women with
low viral loads and good CD4 counts do not need
antiretroviral therapy and should be managed the
same in the first trimester as in the non-pregnant
state.4 15 Providing this information and basic
reproductive care in this setting could be per-
ceived as unjustified since the medical interven-
tion is putting a child-to-be at risk of acquiring
HIV. This objection is obviously focused only on
the clinician’s duty towards the patient, while
significantly less attention is given to the repro-
ductive desires and rights of women with HIV.
The demonstrated efficacy of interventions to
reduce vertical transmission (2% average between
studies v 21% before introduction of vertical
transmission preventive measures)16 17 seems now
to have lowered the opposition to take into
consideration the desire of motherhood in this
infective setting. It should be stressed that
women with HIV infection, when refused coun-
selling and help, may try for a pregnancy without
medical advice with an increase of the risk of
sexual and vertical transmission. Women with
other transmissible diseases, either infective as
hepatitis C or genetic as cystic fibrosis, receive
counselling and are permitted to make their own
decisions whether the risk of having an affected
child is acceptable to them, even when this risk
can be as high as 50%. It seems difficult to deny
reproductive counselling and treatment to
women infected with HIV as this can reduce the
risk of infection for the seronegative partner to
zero and reduce tenfold the possibility of trans-
mission to the child.18–21
Reproductive counselling to HIV infected
women was considered a taboo until recently, but
this slight change is due to the improvement of
their health conditions and the marked reduction
in vertical transmission. Difficulties exist for HIV
infected women who cannot conceive spontane-
ously, as most centres are still reluctant to provide
them with full infertility care when required. This
discrimination against the reproductive rights of
women infected with HIV remains while their
chances of having a child are left to the
willingness of the infertility specialists to provide
reproductive assistance to achieve conception.22 23
SCENARIO 3
When both partners are HIV positive and want to
have a child, the basic ethical dilemma faced by
the clinician remains the same: medical interven-
tion may put a new life at risk of infection with
HIV. The setting in which the decision to provide
assistance takes place is, however, different, as the
possibility that both mother and father may die of
their infection should be taken into account, with
the child growing up without a parent. We
present a couple whom we saw in the early 1990s
and discuss how, owing to the improved progno-
sis for mother and baby, we believe our refusal to
treat them is no longer appropriate.24
In this case, the couple had presented with sec-
ondary infertility, both having had children with
previous partners. They had both tested positive
for antibodies to HIV-1 in 1989 and the infection
had probably occurred through heterosexual
transmission. Serum P24 antigen was not found
in either of them, the T4 lymphocyte number was
low in the man and at the lower limit of normal in
the woman. Investigations had also revealed that
polycystic ovarian disease and oligospermia were
the cause for their infertility. From an infertility
viewpoint, the treatment option then included in
vitro fertilisation. However in view of their HIV
status, after considering all possible implications,
they were refused any active treatment for their
secondary infertility. This decision was based on
the poor prognosis (morbidity and mortality) for
HIV patients and the high risk of vertical
transmission (14–25%) in early 1990s.
Discussion
In the past 10 years, significant advances have
been achieved in controlling HIV infection and
preventing vertical transmission so as to change
the reproductive prospects of infected
individuals.4 15 Men and women with HIV infec-
tion should be informed of the specific measures
to be adopted when they want to have a child. The
rate of infertility in these couples may be higher
owing to their previous or present life style, less
efficient response to infection, and the side effects
of psychoactive drugs or antiretroviral com-
pounds. The progress in the efficacy of anti-
retroviral treatment in controlling the disease and
the availability of specific measures (semen
washing, elective abdominal delivery) to limit the
risk of sexual and materno-fetal infection16 17 25 26
has been reflected in the response of some gynae-
cologists attending to the reproductive desires of
these couples. However, this change of attitude
has been slow and controversial. The couple
presented above would probably have received
proper counselling and care if they had achieved a
pregnancy on their own, but were denied
treatment when the doctors had to take part in
achieving fertilisation. In essence, they were
refused treatment not because of infection but
because of their infertility problem. This seems a
controversial decision making process, but fully
reflects the difficulties both these couples and
their doctors face when decisions entail potential
risks for healthy individuals. The “do no harm”
comes into question when doctors have to take an
active part in the treatment and thus need to take
their share of risk and responsibilities. The duty of
the medical practitioner is not only to provide
appropriate counselling and optimal care but also
to provide protection from the known risks.
CONCLUSION
HIV is now classified as a chronic disease in the
Western world because of a significant increase in
the quality of life and expectancy with the intro-
duction of highly active antiretroviral therapy.
This, along with the developments in reducing
vertical transmission and partner infection, has
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made it necessary to openly re-discuss the repro-
ductive desires and rights of HIV infected
individuals so as to provide the doctors involved
in their care with recommendations.
We also know that 75% of those infected with
HIV are in their childbearing years and therefore
it is important that this issue is addressed. Our
centre is conducting a questionnaire survey of
fertility and genitourinary clinics to assess the
fertility options currently available to these
couples nationwide (Gilling-Smith C and Frod-
sham L, personal communication). We believe
that an open discussion and availability of guide-
lines will enable the medical practitioner to deal
with the reproductive options of these couples in
a scientific and ethically appropriate manner.
To summarise, the above recommendations
seems to us to fulfil the four underlying ethical
principles:
(i) Primum non nocere: first of all, do no
harm
The interventions reduce the existing risks of the
mother and the fetus to a very low level. So far, no
follow up data have suggested that any of these
interventions will cause harm.
(ii) Beneficence: do good
The couples desperately want to have healthy
children. In offering these interventions the
chances that they can achieve this is increased.
(iii) Autonomy: respect the individual
The couples’ informed choice should be respected
in the presence of treatment success. Why should
these couples be denied treatment in 2003?
(iv) Justice: honest and fair care
Denial of any infertility treatment for HIV couples
now would be inappropriate as the above princi-
ples can be applied to the child also.
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